Matrone Carmela, Dzamko Nicolas, Madsen Peder, Nyegaard Mette, Pohlmann Regina, Søndergaard Rikke V, Lassen Louise B, Andresen Thomas L, Halliday Glenda M, Jensen Poul Henning, Nielsen Morten S
Department of Biomedicine, Faculty of Health, Aarhus University, 8000 Aarhus C, Denmark.
Neuroscience Research Australia, Sydney, NSW 2031, and School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia.
PLoS One. 2016 Aug 10;11(8):e0160501. doi: 10.1371/journal.pone.0160501. eCollection 2016.
Increasing evidence points to defects in autophagy as a common denominator in most neurodegenerative conditions. Progressive functional decline in the autophagy-lysosomal pathway (ALP) occurs with age, and the consequent impairment in protein processing capacity has been associated with a higher risk of neurodegeneration. Defects in cathepsin D (CD) processing and α-synuclein degradation causing its accumulation in lysosomes are particularly relevant for the development of Parkinson's disease (PD). However, the mechanism by which alterations in CD maturation and α-synuclein degradation leads to autophagy defects in PD neurons is still uncertain. Here we demonstrate that MPR300 shuttling between endosomes and the trans Golgi network is altered in α-synuclein overexpressing neurons. Consequently, CD is not correctly trafficked to lysosomes and cannot be processed to generate its mature active form, leading to a reduced CD-mediated α-synuclein degradation and α-synuclein accumulation in neurons. MPR300 is downregulated in brain from α-synuclein overexpressing animal models and in PD patients with early diagnosis. These data indicate MPR300 as crucial player in the autophagy-lysosomal dysfunctions reported in PD and pinpoint MRP300 as a potential biomarker for PD.
越来越多的证据表明,自噬缺陷是大多数神经退行性疾病的一个共同特征。自噬-溶酶体途径(ALP)的功能会随着年龄的增长而逐渐衰退,蛋白质加工能力的相应受损与神经退行性变的较高风险相关。组织蛋白酶D(CD)加工缺陷和α-突触核蛋白降解异常导致其在溶酶体中积累,这与帕金森病(PD)的发生发展尤为相关。然而,CD成熟和α-突触核蛋白降解的改变导致PD神经元自噬缺陷的机制仍不明确。在此,我们证明在过表达α-突触核蛋白的神经元中,穿梭于内体和反式高尔基体网络之间的MPR300发生了改变。因此,CD无法正确转运至溶酶体,不能被加工成其成熟的活性形式,导致CD介导的α-突触核蛋白降解减少以及α-突触核蛋白在神经元中积累。在过表达α-突触核蛋白的动物模型的大脑以及早期诊断的PD患者中,MPR300表达下调。这些数据表明MPR300是PD中报道的自噬-溶酶体功能障碍的关键因素,并指出MRP300是PD的一个潜在生物标志物。